Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dan M Granoff

Showing results (31-40 of 91) with videos related to

Pageof 10
Sort By:
Vaccine|May 9, 2006
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870Oliver Koeberling, Jo Anne Welsch, Dan M Granoff
Infection and Immunity|December 3, 2008
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit seraDan M Granoff, Jo Anne Welsch, Sanjay Ram
Plos One|August 19, 2015
A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbpMonica Konar, Peter T Beernink, Dan M Granoff
Infection and Immunity|May 23, 2012
Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor HRolando Pajon, Peter T Beernink, Dan M Granoff
The Pediatric Infectious Disease Journal|August 6, 2004
Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemicAdil A Ismail, Shannon L Harris, Dan M Granoff
Infection and Immunity|February 4, 2015
Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activitySerena Giuntini, Rolando Pajon, Sanjay Ram, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2008
Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2Oliver Koeberling, Serena Giuntini, Anja Seubert, et al.
Clinical and Vaccine Immunology : CVI|April 3, 2009
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activityJoyce S Plested, Jo Anne Welsch, Dan M Granoff
Vaccine|January 19, 2011
Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigenDavid M Vu, Tracy T Wong, Dan M Granoff
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccineJo Anne Welsch, Raffaella Rossi, Maurizio Comanducci, et al.
Pageof 10

Showing results (31-40 of 91) with videos related to

Sort By:
Pageof 10
Vaccine|May 9, 2006
Improved immunogenicity of a H44/76 group B outer membrane vesicle vaccine with over-expressed genome-derived Neisserial antigen 1870Oliver Koeberling, Jo Anne Welsch, Dan M Granoff
Infection and Immunity|December 3, 2008
Binding of complement factor H (fH) to Neisseria meningitidis is specific for human fH and inhibits complement activation by rat and rabbit seraDan M Granoff, Jo Anne Welsch, Sanjay Ram
Plos One|August 19, 2015
A Newly-Identified Polymorphism in Rhesus Macaque Complement Factor H Modulates Binding Affinity for Meningococcal FHbpMonica Konar, Peter T Beernink, Dan M Granoff
Infection and Immunity|May 23, 2012
Design of meningococcal factor H binding protein mutant vaccines that do not bind human complement factor HRolando Pajon, Peter T Beernink, Dan M Granoff
The Pediatric Infectious Disease Journal|August 6, 2004
Serum group a anticapsular antibodies in a Sudanese population immunized with meningococcal polysaccharide vaccine during a group A epidemicAdil A Ismail, Shannon L Harris, Dan M Granoff
Infection and Immunity|February 4, 2015
Binding of complement factor H to PorB3 and NspA enhances resistance of Neisseria meningitidis to anti-factor H binding protein bactericidal activitySerena Giuntini, Rolando Pajon, Sanjay Ram, et al.
Clinical and Vaccine Immunology : CVI|December 26, 2008
Meningococcal outer membrane vesicle vaccines derived from mutant strains engineered to express factor H binding proteins from antigenic variant groups 1 and 2Oliver Koeberling, Serena Giuntini, Anja Seubert, et al.
Clinical and Vaccine Immunology : CVI|April 3, 2009
Ex vivo model of meningococcal bacteremia using human blood for measuring vaccine-induced serum passive protective activityJoyce S Plested, Jo Anne Welsch, Dan M Granoff
Vaccine|January 19, 2011
Cooperative serum bactericidal activity between human antibodies to meningococcal factor H binding protein and neisserial heparin binding antigenDavid M Vu, Tracy T Wong, Dan M Granoff
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2004
Protective activity of monoclonal antibodies to genome-derived neisserial antigen 1870, a Neisseria meningitidis candidate vaccineJo Anne Welsch, Raffaella Rossi, Maurizio Comanducci, et al.
Pageof 10